133 related articles for article (PubMed ID: 1663576)
1. Different antiviral potencies of BV-araU and related nucleoside analogues against herpes simplex virus type 1 in human cell lines and Vero cells.
Machida H; Nishitani M; Suzutani T; Hayashi K
Microbiol Immunol; 1991; 35(11):963-73. PubMed ID: 1663576
[TBL] [Abstract][Full Text] [Related]
2. Antiviral potencies of BV-araU and related nucleoside analogues against varicella-zoster virus in different cell lines.
Machida H; Ijichi K; Ohta A; Honda M; Niimura M
Microbiol Immunol; 1990; 34(11):959-65. PubMed ID: 1965323
[TBL] [Abstract][Full Text] [Related]
3. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
Suzutani T; Machida H; Sakuma T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1046-52. PubMed ID: 2847637
[TBL] [Abstract][Full Text] [Related]
4. Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2.
Suzutani T; Machida H; Sakuma T; Azuma M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1547-51. PubMed ID: 2847634
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.
Machida H; Sakata S
Antiviral Res; 1984 Jun; 4(3):135-41. PubMed ID: 6089657
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
Kawai H; Yoshida I; Suzutani T
Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
[TBL] [Abstract][Full Text] [Related]
7. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P
Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.
Reefschläger J; Pein CD; Cech D
J Med Chem; 1988 Feb; 31(2):393-7. PubMed ID: 2828623
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
Machida H; Watanabe Y
Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
[TBL] [Abstract][Full Text] [Related]
10. Metabolic fate of [3H]1-beta-D-arabinofuranosyl-5-[(E)-2-bromovinyl]uracil in herpes simplex virus type 1-infected cells.
Ashida N; Sakata S; Machida H
Microbiol Immunol; 1997; 41(12):957-64. PubMed ID: 9492181
[TBL] [Abstract][Full Text] [Related]
11. Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
Machida H; Sakata S; Kuninaka A; Yoshino H
Antimicrob Agents Chemother; 1981 Jul; 20(1):47-52. PubMed ID: 6269482
[TBL] [Abstract][Full Text] [Related]
12. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Sakuma T
Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo anti-herpes viral activities and biological properties of CV-araU.
Ashida N; Sakata S; Kano F; Nishitani M; Watanabe Y; Machida H
Antiviral Res; 1994 Dec; 25(3-4):179-84. PubMed ID: 7710267
[TBL] [Abstract][Full Text] [Related]
14. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
Reefschläger J; Bärwolff D; Herrmann G; Langen P
Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus type 1 infection in immunosuppressed mice.
Ijichi K; Ashida N; Machida H
Antimicrob Agents Chemother; 1990 Dec; 34(12):2431-3. PubMed ID: 1965108
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
[TBL] [Abstract][Full Text] [Related]
17. In vitro drug combination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil with anti-human immunodeficiency virus or anticancer nucleosides.
Machida H; Ashida N; Ikeda T; Sakata S; Baba M; Shigeta S
Antimicrob Agents Chemother; 1992 Jan; 36(1):214-6. PubMed ID: 1317147
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment with BV-araU of immunosuppressed and immunocompetent shaved mice cutaneously infected with herpes simplex virus type 1.
Ijichi K; Ashida N; Varia S; Machida H
Antiviral Res; 1993 May; 21(1):47-57. PubMed ID: 8391248
[TBL] [Abstract][Full Text] [Related]
19. Analysis of toxic and mutagenic activities of antiherpesvirus nucleosides against HeLa cells and herpes simplex virus type 1.
Suzutani T; Machida H
Mutat Res; 1992 May; 267(1):125-31. PubMed ID: 1373847
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral treatment with BV-araU against cutaneous infection with herpes simplex type 1 in shaved mice.
Machida H; Ijichi K; Takezawa J
Antiviral Res; 1992 Feb; 17(2):133-43. PubMed ID: 1554238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
